Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, is scheduled to present on Thursday, February 25th, 2021 at 12:00 p.m. EST and will discuss the Company’s progress and outlook.
The presentation will be webcast live and available for replay here and via the investor relations section of the Company’s website at www.anavex.com
Would love to know the progress regarding discussions with FDA.
Also more info about PDD, Rett and that new indication.
Time to break the suspense.